Sabby Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Sabby Management’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,013	Closed	-$294K	–	393
2015 Q1	$294K	Buy	+3,013	New	+$319K	0.01%	253
2014 Q4	–	Sell	-145,200	Closed	-$9.99K	–	312
2014 Q3	$9.99K	Buy	+145,200	New	+$10.4M	0.38%	42
2014 Q2	–	Sell	-13,538	Closed	-$1.15M	–	307
2014 Q1	$1.12M	Buy	+13,538	New	+$1.25M	0.06%	132

Sabby Management's GEVA Position: Q2 2015 in Review

Sabby Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 3,013 shares — an estimated $294K sold.

Sabby Management first reported a position in GEVA in Q1 2014 and held it in 3 quarters. The position peaked at $1.12M in Q1 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Sabby Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Sabby Management sold 3,013 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $294K.
Sabby Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2014 and held it in 3 quarters.
Sabby Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.12M in Q1 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Sabby Management's 13F filing for Q2 2015, filed 14 Aug 2015.